ArticleFrontiers in immunology2022

The STING agonist, DMXAA, reduces tumor vessels and enhances mesothelioma tumor antigen presentation yet blunts cytotoxic T cell function in a murine model.

Peter T Graham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.